Autres langues Centogene N.V.

Actions

CNTG

NL0014040206

Marché Fermé - Nasdaq Autres places de cotation 22:30:00 31/05/2024			Varia. 5j.	Varia. 1 janv.
0,371 ^USD	-0,27 %		-0,80 %	-69,08 %

16/05	La série de données économiques à venir stimule les fonds négociés en bourse et les contrats à terme sur actions avant la cloche de jeudi	MT
16/05	Les plus fortes hausses du prémarché	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Upcoming Slew of Economic Data Buoys Exchange-Traded Funds, Equity Futures Pre-Bell Thursday	16/05
Top Premarket Gainers	16/05
Centogene N.V. Provides Earnings Guidance for the Year 2024	15/05
Centogene, Evotec Discover New Molecule for Potential Gaucher Disease Treatment	14/05
Centogene N.V and Evotec SE Discovers Promising New Molecule to Treat Gaucher Disease	14/05
Centogene Biodatabank Grows to Incorporate Disease Insights from over 850,000 Diverse Patients	10/05
Centogene, Takeda Pharmaceutical Collaborate on Lysosomal Storage Disorders Diagnostics	19/03
Centogene N.V. Announces the Extension of an Ongoing Partnership with Takeda to Continue Providing Access to Genetic Testing for Patients with Lysosomal Storage Disorders	19/03
Centogene Explores Strategic Alternatives	28/02
Centogene N.V. and the Laboratory of Human Genetics of Infectious Diseases At Institut Imagine Announce Rare Disease Research Collaboration	25/01
Centogene N.V. and The Michael J. Fox Foundation for Parkinson's Research Announces Research Project to Validate Genetic Risk Factors of Parkinson's Disease Using Multiomics	23/01
Centogene N.V. Provides Earnings Guidance for the Full Year 2023	18/01
Centogene N.V. Announces Changes to Supervisory Board	18/12
Centogene N.V.'s Frontotemporal Dementia Genetic Study, EFRONT, Reaches Initial Patient Enrollment Milestone	13/12
Centogene N.V. and Lifera Complete Strategic Joint Venture Transaction	28/11
Centogene N.V. Announces the Discovery of A New Form of Early-Onset Dystonia and Parkinsonism	14/11
Centogene N.V. Expands Multiomic Diagnostic Portfolio with Newly-Launched Transcriptomic Offering	10/10/23
Flemming Ornskov Decides to Step Down from His Role as a Member of the Supervisory Board of Centogene	06/10/23
Centogene N.V. Reports Earnings Results for the Half Year Ended June 30, 2023	07/09/23
Centogene N.V. Reaffirms Revenue Guidance for the Year 2023	07/09/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Centogene N.V.

Actions

CNTG

NL0014040206

Autres langues

Filtres